SETNEWA
Live / Allowed — Approved for publication (as of 18 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 May 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99840166
- Mark type
- Stylized text
- Filed
- 22 May 2026
- Attorney of record
- Xiomara Triana
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, autoimmune diseases, solid organ transplant rejection, autoinflammatory diseases, blood diseases, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, Alzheimer’s disease, autism spectrum disorder, and musculoskeletal and skin diseases; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes
Owner
- Juno Therapeutics, Inc., Seattle, WA, US
Prosecution history
- 18 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Sept 2026 — ASSIGNED TO EXAMINER
- 22 May 2026 — APPLICATION FILING RECEIPT MAILED
- 22 May 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 May 2026 — NEW APPLICATION ENTERED